Bioconjugation Process Services

Bioconjugation Process Services
Product Description

Intellective Bio provides an integrated Bioconjugation Process Development Platform, offering end-to-end services for ADCs, AOCs, DACs, APCs, ISACs, RDCs, etc.. Our services span early-stage research, process development, optimization, technology transfer and process characterization. Leveraging advanced conjugation technologies and extensive expertise, the platform helps reduce production costs, shorten development timelines, and accelerate regulatory submissions and commercialization for the global clients.

Intellective Bio

  • Country/Region:
    China
  • On CPHI since:
    2026

Intellective Bio

  • Country/Region:
    China
  • On CPHI since:
    2026

More Products from Intellective Bio (4)

  • Drug Product

    Product Drug Product

    Intellective Bio offers aseptic filling services that ensure the highest quality and safety for large-scale production. Our flexible drug product lines support multiple dosage forms, including vials (liquid), lyophilized formulations, and pre-filled syringes (PFS). The facilities have successfully passed N...
  • Drug Substance

    Product Drug Substance

    With a strong track record of high batch success rates, Intellective Bio ensures superior product quality and safety, enabling a seamless transition from clinical to commercial manufacturing. Our drug substance production facilities are equipped with bioreactors ranging from 200 L to 6,000 L, available in ...
  • Process Development

    Product Process Development

    Intellective Bio’s process development services have established a comprehensive, end-to-end integrated platform that spans upstream cell culture to downstream protein purification. The platform is dedicated to delivering efficient, robust, and scalable manufacturing process solutions for clients.
  • Quality Policy

    Product Quality Policy

    With "excellent quality and compliance first" as the core, we establish the quality management system covering the entire life cycle of pharmaceuticals, integrating global regulatory requirements such as NMPA, US FDA, EMA, and ICH guidelines, to ensure that every link from research and development to comme...